PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,950 | -21.1% | 16,864 | -9.4% | 0.00% | – |
| Q2 2023 | $84,894 | -10.8% | 18,617 | +2.7% | 0.00% | – |
| Q1 2023 | $95,167 | +13.9% | 18,127 | +6.4% | 0.00% | – |
| Q4 2022 | $83,527 | -24.8% | 17,030 | -1.2% | 0.00% | – |
| Q3 2022 | $111,000 | +0.9% | 17,236 | -0.6% | 0.00% | – |
| Q2 2022 | $110,000 | -14.7% | 17,346 | -7.5% | 0.00% | – |
| Q1 2022 | $129,000 | -3.7% | 18,756 | -1.9% | 0.00% | – |
| Q4 2021 | $134,000 | -18.8% | 19,125 | -2.9% | 0.00% | – |
| Q3 2021 | $165,000 | +20.4% | 19,688 | +0.2% | 0.00% | – |
| Q2 2021 | $137,000 | +12.3% | 19,647 | +0.2% | 0.00% | – |
| Q1 2021 | $122,000 | +0.8% | 19,616 | -17.4% | 0.00% | – |
| Q4 2020 | $121,000 | 0.0% | 23,757 | -13.3% | 0.00% | – |
| Q3 2020 | $121,000 | -19.9% | 27,414 | +0.3% | 0.00% | – |
| Q2 2020 | $151,000 | -7.9% | 27,326 | +0.5% | 0.00% | – |
| Q1 2020 | $164,000 | -33.1% | 27,186 | +1.6% | 0.00% | – |
| Q4 2019 | $245,000 | -1.2% | 26,768 | -2.0% | 0.00% | – |
| Q3 2019 | $248,000 | -14.5% | 27,304 | -5.3% | 0.00% | – |
| Q2 2019 | $290,000 | -43.1% | 28,822 | -20.8% | 0.00% | – |
| Q1 2019 | $510,000 | -26.3% | 36,373 | -16.6% | 0.00% | – |
| Q4 2018 | $692,000 | -17.9% | 43,614 | -2.7% | 0.00% | – |
| Q3 2018 | $843,000 | +12.3% | 44,829 | +14.8% | 0.00% | – |
| Q2 2018 | $751,000 | -10.4% | 39,046 | -0.5% | 0.00% | – |
| Q1 2018 | $838,000 | +2.8% | 39,246 | -0.9% | 0.00% | – |
| Q4 2017 | $815,000 | +19.7% | 39,621 | +7.3% | 0.00% | – |
| Q3 2017 | $681,000 | -28.5% | 36,927 | -3.4% | 0.00% | – |
| Q2 2017 | $953,000 | +145.0% | 38,227 | +96.5% | 0.00% | – |
| Q1 2017 | $389,000 | -7.6% | 19,449 | +13.8% | 0.00% | – |
| Q4 2016 | $421,000 | +27.2% | 17,084 | +2.1% | 0.00% | – |
| Q3 2016 | $331,000 | +56.1% | 16,739 | +8.6% | 0.00% | – |
| Q2 2016 | $212,000 | 0.0% | 15,415 | 0.0% | 0.00% | – |
| Q1 2016 | $212,000 | +47.2% | 15,415 | +8.5% | 0.00% | – |
| Q4 2015 | $144,000 | +6.7% | 14,209 | +5.2% | 0.00% | – |
| Q3 2015 | $135,000 | -28.2% | 13,509 | +6.7% | 0.00% | – |
| Q2 2015 | $188,000 | -23.9% | 12,662 | -15.0% | 0.00% | – |
| Q1 2015 | $247,000 | +1.2% | 14,894 | -7.3% | 0.00% | – |
| Q4 2014 | $244,000 | +7.0% | 16,066 | -0.3% | 0.00% | – |
| Q3 2014 | $228,000 | -2.6% | 16,120 | -2.4% | 0.00% | – |
| Q2 2014 | $234,000 | -17.6% | 16,513 | -0.2% | 0.00% | – |
| Q1 2014 | $284,000 | +54.3% | 16,548 | +32.0% | 0.00% | – |
| Q4 2013 | $184,000 | +10.2% | 12,538 | -0.8% | 0.00% | – |
| Q3 2013 | $167,000 | +11.3% | 12,638 | -9.6% | 0.00% | – |
| Q2 2013 | $150,000 | – | 13,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |